查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1363960

全球大麻二酚油市場 2023-2030

Global Cannabidiol Oil Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 95 Pages | 商品交期: 2-3個工作天內

價格

預計全球大麻二酚油市場在預測期內將以 16.3% 的年複合成長率成長。人們對大麻二酚的益處及其藥用特性的認知不斷提高，推動了其需求；這反過來又推動了全球大麻二酚油的成長。此外，大麻油在製藥行業中的廣泛採用，因為它可以減輕身體疼痛，這是一個積極的訊號，進一步促進了市場的成長。由於政府批准，CBD 產品的接受度和使用量不斷增加，預計將促進生產和銷售，從而促進市場成長。 CBD 可以有效治療焦慮、癲癇和疼痛等疾病。

此外，正在進行的研發活動旨在尋找 CBD 油在治療領域的效用，這進一步為市場成長創造了空間。例如，根據密西根大學2021 年6 月發表的一項研究，在878 名纖維肌痛患者中，72.0% 的患者報告使用CBD 來控制疼痛，與其他藥物療法相比，CBD 有助於減輕他們的疼痛。因此，CBD油基產品的廣泛使用以及消費者觀念的變化一直推動著市場的成長。然而，嚴格的監管政策和副作用以及假冒產品的出現正在限制全球大麻二酚油市場的成長。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地理

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Medical Marijuana, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • ConnOils LLC
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • NuLeaf Naturals, LLC
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Elixinol
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展

第 4 章：市場決定因素

  • 激勵因素
  • 限制
  • 機會

第 5 章：市場細分

  • 全球大麻二酚油市場（按產品）
    • 以大麻為基礎
    • 大麻基
  • 全球大麻二酚油市場按應用
    • 多發性硬化症
    • 憂鬱症和睡眠障礙
    • 神經性疼痛
    • 其他應用

第 6 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 7 章：公司簡介

  • Aurora Cannabis
  • Canopy Growth Corp.
  • CBD American Shaman
  • ConnOils LLC
  • CV Sciences Inc.
  • Elixinol
  • ENDOCA
  • Folium Europe B.V.
  • Gaia Herbs
  • Hempstrol
  • High Tide, Inc.
  • IRIE CBD
  • Isodiol International Inc
  • Medical Marijuana, Inc.
  • NuLeaf Naturals, LLC
Product Code: OMR2027715

Title: Global Cannabidiol oil Market Size, Share & Trends Analysis Report Market, By Product Type (Marijuana Based, Hemp Based), By Application (Multiple Sclerosis, Depression and Sleep Disorders, Neurological Pain, Other Application)Forecast Period (2023-2030).

The global cannabidiol oil market is anticipated to grow at a considerable CAGR of 16.3% during the forecast period. The increased awareness about the benefits of cannabidiol and its medicinal properties has driven its demand; which in turn driving the growth of the global cannabidiol oil. Additional, the high adoption of hemp oil in pharmaceutical industries as it reduces the body pain is a positive sign is further contributing to the market growth. The increasing acceptance and use of CBD products due to government approvals is anticipated to boost production and sales, thereby contributing to the market growth. CBD effectively treats conditions, such as anxiety, seizures, and pain.

Moreover, the ongoing R&D activities in finding the utility of CBD oil in therapeutic areas is further creating scope for the market growth. For instance, according to a study from Michigan University published in June 2021, out of 878 patients with fibromyalgia, 72.0% of patients reported using CBD to manage their pain, and CBD helped decrease their pain compared to other drug therapies. Thus, the widespread use of CBD oil-based products, along with changing consumer opinion has been driving the market growth. However, stringent regulatory policies and side effects, and availability counterfeit products are restraining the growth of the global cannabidiol oil market.

Segmental Outlook

The global cannabidiol oil market is segmented based on product type and application. Based on product type, the market is segmented into marijuana based, and hemp based. Based on application, the market is segmented into multiple sclerosis, depression and sleep disorders, neurological pain, and other application.

Hemp Based to Hold Major Market Share

The hemp based CBD oil held major share in the global market in 2022. This segment is projected to exhibit the fastest CAGR during the forecast period. The rising product demand from the pharmaceutical industry and growing consumer awareness about its health benefits is a key contributor to the high share of this market segment. Moreover, legalizing medicinal cannabis and increasing consumer disposable income levels are projected to fuel the demand for hemp based CBD in the pharmaceutical sector.

Regional Outlook

The global cannabidiol oil market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit fastest CAGR in the cannabidiol oil market during the forecast period.

North America Held Significant Share in the Global Cannabidiol Oil Market

North America held significant share in the global cannabidiol oil market. The growing beauty & cosmetic industry of the region, high adoption of CBD oil in several medicines, along with the presence of key market players are key factors driving the growth of the regional market. Moreover, the ongoing R&D activities in finding the utility of CBD oil in therapeutic areas is further creating scope for the regional market growth.

For instance, in March 2021, Advanced Pain and Rehab Specialists, in collaboration with Hemp synergistic, conducted a phase I clinical trial to assess the efficacy of Hemp Oil (CBD) for treating pain, anxiety, insomnia, and reduction of opioid use. Additionally, in June 2021, The Valens Company Inc. completed the acquisition of Green Roads and its manufacturing subsidiary. With this acquisition, Valens Company is anticipated to have one of the largest players in the cannabinoid oil market. The increasing market player's activities in the region are expected to increase product availability in the region.

Market Players Outlook

The major companies serving the global cannabidiol oil market include Aurora Cannabis, Medical Marijuana, Inc., ConnOils LLC, NuLeaf Naturals, LLC, and Elixinol among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, dealership expansion, and new product launches, to stay competitive in the market. For instance, in February 2023, Multi-platinum entertainer Sara Evans has partnered with Nashville-based CeleBriDy Brands to develop Born to Fly CBD by Sara Evans. The luxurious new product line is available in both an oil tincture and as a topical roll-on for fast, targeted pain relief.

In December 2022, Medterra has announced a national distribution partnership with Gopuff, the innovative, instant delivery platform for customers' daily needs. Medterra officially launched on Gopuff this past Summer in select markets, for residents in Arizona, California, Pennsylvania and Illinois and is now in 26 additional markets with further plans for expansion through 2022 and 2023. Such expansion plans are creating new scope for the market growth in new markets.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global cannabidiol oil market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Medical Marijuana, Inc.
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. ConnOils LLC
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. NuLeaf Naturals, LLC
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Elixinol
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cannabidiol Oil Market by Product
    • 5.1.1. Marijuana Based
    • 5.1.2. Hemp Based
  • 5.2. Global Cannabidiol Oil Market by Application
    • 5.2.1. Multiple Sclerosis
    • 5.2.2. Depression and Sleep Disorders
    • 5.2.3. Neurological Pain
    • 5.2.4. Other Application

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Aurora Cannabis
  • 7.2. Canopy Growth Corp.
  • 7.3. CBD American Shaman
  • 7.4. ConnOils LLC
  • 7.5. CV Sciences Inc.
  • 7.6. Elixinol
  • 7.7. ENDOCA
  • 7.8. Folium Europe B.V.
  • 7.9. Gaia Herbs
  • 7.10. Hempstrol
  • 7.11. High Tide, Inc.
  • 7.12. IRIE CBD
  • 7.13. Isodiol International Inc
  • 7.14. Medical Marijuana, Inc.
  • 7.15. NuLeaf Naturals, LLC

LIST OF TABLES

  • 1. GLOBAL CANNABIDIOL OIL MARKET BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL MARIJUANA BASED CANNABIDIOL OIL MARKET BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL HEMP BASED CANNABIDIOL OIL MARKET BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CANNABIDIOL OIL MARKET BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL CANNABIDIOL OIL FOR MULTIPLE SCLEROSIS TREATMENT MARKET BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL CANNABIDIOL OIL FOR DEPRESSION AND SLEEP DISORDERS TREATMENT MARKET BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL CANNABIDIOL OIL FOR NEUROLOGICAL PAIN TREATMENT MARKET BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL CANNABIDIOL OIL FOR OTHER APPLICATION MARKET BY REGION,2022-2030 ($ MILLION)
  • 9. GLOBAL CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. EUROPEAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 14. EUROPEAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 15. EUROPEAN CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. ASIA-PACIFIC CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD CANNABIDIOL OIL MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CANNABIDIOL OIL MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL CANNABIDIOL OIL MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 3. GLOBAL CANNABIDIOL OIL MARKET SHARE BY GEOGRAPHY, 2022 VS 2030, (%)
  • 4. GLOBAL MARIJUANA BASED CANNABIDIOL OIL MARKET BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL HEMP BASED CANNABIDIOL OIL MARKET BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL CANNABIDIOL OIL FOR MULTIPLE SCLEROSIS TREATMENT MARKET BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL CANNABIDIOL OIL FOR DEPRESSION AND SLEEP DISORDERS TREATMENT MARKET BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL CANNABIDIOL OIL FOR NEUROLOGICAL PAIN TREATMENT MARKET BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL CANNABIDIOL OIL FOR OTHER APPLICATION MARKET BY REGION, 2022 VS 2030 (%)
  • 10. US CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA MARKET CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. GERMANY CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. SPAIN CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. FRANCE CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. ITALY CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF WORLD CANNABIDIOL OIL MARKET SIZE, 2022-2030 ($ MILLION)